PR Newswire Government
pressCenter
Autoimmune Uveitis Market to Expand at a CAGR of 7% During the Forecast Period (2026-2036) as Novel Treatments Challenge the Existing Therapeutic Landscape | DelveInsighttranslating…
The autoimmune uveitis market is poised for steady growth, driven by the increasing recognition and diagnosis of non-infectious uveitis, the need for steroid-sparing therapies, and continued advances in targeted immunomodulatory treatments. Growth is expected to accelerate as…
Keywords#Uveitis#Autoimmune Uveitis#Uveitis Market#Treatments#Autoimmune Uveitis Market
Comments
Sign in to join the discussion.
Loading comments…